Chimerism analysis as a predictor of relapse of myelodysplastic syndrome after allogeneic stem cell...
Chimerism analysis as a predictor of relapse of myelodysplastic syndrome after allogeneic stem cell transplantation
About this item
Full title
Author / Creator
Publisher
Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
Introduction: SCT is a potentially curative treatment for myelodysplastic syndrome (MDS), yet associated with a high risk of transplantation related mortality (TRM) and relapse. Chimerism analysis (CA) of peripheral blood (PB) or bone marrow (BM) may predict relapse after SCT, but has not been evaluated specifically for MDS patients. Materials and...
Alternative Titles
Full title
Chimerism analysis as a predictor of relapse of myelodysplastic syndrome after allogeneic stem cell transplantation
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A198170731
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A198170731
Other Identifiers
ISSN
0268-3369
